ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PTEO Proteo Inc (GM)

179.80
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Proteo Inc (GM) USOTC:PTEO OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 179.80 0.00 01:00:00

Proteo Inc - Current report filing (8-K)

11/06/2008 11:01am

Edgar (US Regulatory)



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 5, 2008

PROTEO, INC.

(Exact name of registrant as specified in its charter)

 Nevada 000-32849 88-0292249
(State of other jurisdiction (Commission (IRS Employer
 of incorporation) File Number) Identification No.)

2102 Business Center Drive, Irvine, California 92612
(Address of Principal Executive Offices)

Registrant's telephone number, including area code: (949) 253-4616

Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
|_| Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

On June 9, 2008, the Registrant entered into a Preferred Stock Purchase Agreement (the "Agreement") with FIDEsprit AG, a Swiss corporation (the "Investor"). Pursuant to the Agreement, the Registrant issued and sold to the Investor 600,000 shares of the Registrant's Series A Preferred Stock at a price of $6.00 per share, for an aggregate purchase price $3,600,000. In payment of the purchase price, the Investor delivered to the Registrant a promissory note in the principal amount of $3,600,000. The promissory note does not bear any interest, and is payable as follows: (i) the first installment, in the amount of $900,000, was due upon execution of the Agreement, (ii) the second installment, in the amount of $450,000, is due on or before August 30, 2008, (iii) the third installment, in the amount of $900,000, is due on or before November 30, 2008, and (iv) the final installment, in the amount of $1,350,000, is due on or before March 31, 2009. The promissory note is guaranteed by Axel J. Kutscher. The terms of the Series A Preferred Stock are described in Item 5.03 below. Joerg Alte, a director of the Registrant, is the Managing Director of the Investor.

ITEM 3.02 UNREGISTERED SALES OF EQUITY SECURITIES.

On June 9, 2008 the Registrant entered into the Agreement described in Item 1.01 above. Pursuant to the Agreement the Registrant issued to the Investor 600,000 shares of Series A Preferred Stock in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended, by virtue of the exemptions available under Rule 506 of Regulation D and Regulation S and the rules promulgated thereunder.

ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.

On June 5, 2008, the Registrant filed a Certificate of Designation with the Secretary of State of the State of Nevada to designate 750,000 shares of its authorized preferred stock as Series A Preferred Stock. The Certificate of Designation, a copy of which is attached as Exhibit 3.9 to this Current Report on Form 8-K and incorporated herein by reference, describes the rights, preferences and privileges of the Series A Preferred Stock.

9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(c) Exhibits. The following materials are filed as exhibits to this Current report on Form 8-K:

Exhibit Number

3.9 Certificate of Designation of Series A Preferred Stock dated June 5, 2008
10.8 Preferred Stock Purchase Agreement dated June 9, 2008
10.9 Promissory Note dated June 9, 2008

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PROTEO, INC.

Date: June 9, 2008 By: /s/ BIRGE BARGMANN
 --------------------------------
 Birge Bargmann
 Chief Executive Officer

1 Year Proteo (GM) Chart

1 Year Proteo (GM) Chart

1 Month Proteo (GM) Chart

1 Month Proteo (GM) Chart

Your Recent History

Delayed Upgrade Clock